
    
      An open label, balanced, randomized, two treatment, two sequence, two period, single-dose,
      crossover oral bioequivalence study of Clopidogrel Bisulfate 300 mg Tablets of Dr. Reddy's
      Laboratories Ltd., India and PlavixÂ® (Clopidogrel Bisulfate) 300 mg Tablets of Bristol-Myers
      Squibb/Sanofi pharmaceuticals partnership Bridgewater, NJ 0880750086441, USA, in healthy,
      adult, human male subjects under fed conditions.
    
  